Evidence map›Paper›PMID 22844090›Full record

ArticleNucleic acids research2012

A benchmark for chromatin binding measurements in live cells.

Davide Mazza, Alice Abernathy, Nicole Golob, Tatsuya Morisaki, James G McNally

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed, 334 citations in OpenAlex.

  1. Article
  2. Elevated MyoD1 levels expand genome-wide binding and the repertoire of regulated genes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. The shifting paradigm of chromatin structure: from the 30-nm chromatin fiber to liquid-like organization.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Davide MazzaLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, 20892, Bethesda, MD, USA.
Alice Abernathy
Nicole Golob
Tatsuya Morisaki
James G McNally
IRCCS Ospedale San Raffaele · ITNational Cancer Institute · USNational Institutes of Health · US

Funding

Transcription factor mobilityZIABC010561 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MCNALLY, JAMES G · 2009 to 2013
$3.9M
Fluorescence Imaging FacilityZICBC010571 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MCNALLY, JAMES G · 2009 to 2013
$1.3M
Intramural NIH HHS
6 · The paper itself

Abstract

Live-cell measurement of protein binding to chromatin allows probing cellular biochemistry in physiological conditions, which are difficult to mimic in vitro. However, different studies have yielded widely discrepant predictions, and so it remains uncertain how to make the measurements accurately. To establish a benchmark we measured binding of the transcription factor p53 to chromatin by three approaches: fluorescence recovery after photobleaching (FRAP), fluorescence correlation spectroscopy (FCS) and single-molecule tracking (SMT). Using new procedures to analyze the SMT data and to guide the FRAP and FCS analysis, we show how all three approaches yield similar estimates for both the fraction of p53 molecules bound to chromatin (only about 20%) and the residence time of these bound molecules (∼1.8 s). We also apply these procedures to mutants in p53 chromatin binding. Our results support the model that p53 locates specific sites by first binding at sequence-independent sites.

Indexed as

Fluorescence Recovery After PhotobleachingSpectrometry, FluorescenceCell Line, TumorChromatinHumansKineticsTumor Suppressor Protein p53ChromatinTumor Suppressor Protein p53

Identifiers

PMID22844090
PMCPMC3424588
OpenAlexW2108459914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.